|
gptkbp:instance_of
|
gptkb:Person
|
|
gptkbp:affiliation
|
gptkb:Genentech
gptkb:University_of_California,_San_Francisco
gptkb:Gates_Foundation
|
|
gptkbp:alma_mater
|
gptkb:University_of_California,_Berkeley
gptkb:University_of_California,_San_Francisco
|
|
gptkbp:award
|
National Academy of Medicine member
American Academy of Arts and Sciences member
Institute of Medicine member
|
|
gptkbp:birth_date
|
1959-04-01
|
|
gptkbp:birth_place
|
gptkb:San_Francisco,_California
|
|
gptkbp:children
|
2
|
|
gptkbp:contribution
|
development of Avastin
development of Herceptin
development of Tarceva
|
|
gptkbp:field
|
gptkb:biotechnology
gptkb:Medicine
public health
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Susan Desmond-Hellmann
|
|
gptkbp:influenced_by
|
gptkb:Francis_Collins
gptkb:David_Baltimore
gptkb:Harold_Varmus
|
|
gptkbp:involvement
|
gptkb:Health_Insurance
gptkb:educational_programs
mentorship programs
community health initiatives
clinical research
biomedical research
global health initiatives
philanthropic efforts
healthcare innovation
research collaborations
scientific advisory boards
advocacy for women in science
|
|
gptkbp:known_for
|
advancements in cancer research
leadership in biotechnology
leadership in public health initiatives
|
|
gptkbp:nationality
|
gptkb:American
|
|
gptkbp:occupation
|
gptkb:pharmaceuticals
gptkb:Biology
|
|
gptkbp:position_held
|
CEO of the Bill & Melinda Gates Foundation
Chancellor of the University of California, San Francisco
|
|
gptkbp:research_areas
|
gptkb:Health_Insurance
oncology
pharmaceutical sciences
|
|
gptkbp:research_focus
|
clinical trials
drug development
cancer therapeutics
|
|
gptkbp:spouse
|
gptkb:David_Hellmann
|
|
gptkbp:bfsParent
|
gptkb:University_of_California,_San_Francisco
gptkb:University_of_California,_San_Diego
|
|
gptkbp:bfsLayer
|
4
|